- 同花顺特色产品
- 〈高级诊股〉全方位深度分析，提供明确投资建议
- 〈舆情监控〉实时监控个股情报
- 短期趋势：
股价的强势特征已经确立，短线可能回调。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
迄今为止，共87家主力机构，持仓量总计365.49万股，占流通A股7.40%
- 波段诊断：
-
技术面诊股
诊断结果：9.0技术面打败了96%的股票
技术面评分前10的股票
近期的平均成本为740.24元，股价在成本上方运行。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为740.24元，股价在成本上方运行。
[{"text":"\u5e73\u5747\u6210\u672c","value":"740.24","date":1624522739,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2021.06.25","stock":"9.04","trade":"1.56","ind":"1.48"},{"date":"2021.06.24","stock":"-1.55","trade":"-1.80","ind":"-0.40"},{"date":"2021.06.23","stock":"1.01","trade":"-0.14","ind":"1.00"},{"date":"2021.06.22","stock":"0.43","trade":"0.85","ind":"0.38"},{"date":"2021.06.21","stock":"4.86","trade":"3.08","ind":"0.40"},{"date":"2021.06.18","stock":"4.66","trade":"1.60","ind":"0.77"},{"date":"2021.06.17","stock":"2.55","trade":"0.63","ind":"1.23"},{"date":"2021.06.16","stock":"-5.66","trade":"-1.73","ind":"-2.57"},{"date":"2021.06.15","stock":"-0.48","trade":"-1.10","ind":"-0.86"},{"date":"2021.06.11","stock":"1.49","trade":"-1.54","ind":"-0.62"},{"date":"2021.06.10","stock":"1.17","trade":"-0.18","ind":"1.19"},{"date":"2021.06.09","stock":"-0.93","trade":"-0.07","ind":"0.01"},{"date":"2021.06.08","stock":"0.59","trade":"-1.47","ind":"-0.98"},{"date":"2021.06.07","stock":"-1.30","trade":"0.48","ind":"-0.06"},{"date":"2021.06.04","stock":"1.99","trade":"0.57","ind":"0.74"},{"date":"2021.06.03","stock":"2.41","trade":"-1.24","ind":"-0.65"},{"date":"2021.06.02","stock":"-8.81","trade":"-3.13","ind":"-1.18"},{"date":"2021.06.01","stock":"0.49","trade":"1.10","ind":"0.26"},{"date":"2021.05.31","stock":"3.15","trade":"3.97","ind":"0.97"},{"date":"2021.05.28","stock":"-1.44","trade":"-1.27","ind":"-0.30"},{"date":"2021.05.27","stock":"1.31","trade":"1.39","ind":"0.70"}]
爱美客,深证成指,医疗器械服务指数
压力支撑
该股压力位为725.45元，支撑位为687.03元。
[{"text":"\u538b\u529b\u4f4d","value":"725.45","date":1624550400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"687.03","date":1624550400,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.1资金面打败了88%的股票
主力控盘前10的股票
行业资金
医疗器械服务行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：06月25日 20:30
| 机构今日流向(万元) | 2760.87 | 机构5日流向(万元) | 3570.40 |
| 机构10日流向(万元) | -1451.01 | 机构20日流向(万元) | -9368.26 |
机构持仓
2021-03-31 与 2020-12-31 相比，主力机构持仓量减少203.35万股，其中基金净增仓24家，主力净减仓1826家，暂未发现中长期投资价值。
截止2021-03-31，共87家主力机构（基金84家，社保基金1家，保险公司1家，券商集合理财1家），持仓量总计365.49万股，占流通A股7.40%
其中，基金持仓与相比：
增仓：26家 ，增持 99.83万股
减仓：2家 ，减持 0.87万股
新出现在主力名单中：57家 ，持有190.37万股
从主力名单中消失：1883家 ，原持有492.68万股
其中，基金持仓与相比：
增仓：26家 ，增持 99.83万股
减仓：2家 ，减持 0.87万股
新出现在主力名单中：57家 ，持有190.37万股
从主力名单中消失：1883家 ，原持有492.68万股
消息面诊股
诊断结果：5.3消息面打败了36%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 拟赴港二次上市 并购肉毒毒素资产 “医美龙头”爱美
2021-06-25 - 两大重磅消息一出 “女人的茅台”又沸腾了！刚刚 股
2021-06-25 - 爱美客：8.9亿对价获韩国Huons Bio公司2
2021-06-25 - 国内市场提升空间广阔 医美概念股重拾升势
2021-06-25 - 港A两市医美概念股集体爆发 瑞丽医美涨超14% 爱
2021-06-25 - 爱美客：8.9亿对价获韩国Huons Bio公司2
2021-06-25 - 医美概念发力走高 爱美客大涨逾9% 拟豪掷近9亿收
2021-06-25 - 市场规模不断扩大 行业龙头新增8.8亿元大笔收购
2021-06-25 - 医美概念持续拉升
2021-06-25 - 爱美客：6月24日融资净偿还670.44万元 上一
2021-06-25
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2021-06-25 |
| 一般消息 | 募资投向 | 公司购买资产 | 2021-06-25 |
| 一般消息 | 高管变动 | 因个人工作原因 | 2021-06-24 |
| 一般消息 | 募资投向 | 2021-06-24 | |
| 一般消息 | 高管变动 | 个人原因 | 2021-03-25 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2021-03-02 |
| 利好 | 分红转增 | 10转8股派35元(含税) | 2021-02-09 |
| 一般消息 | 募资投向 | 公司购买资产 | 2021-02-09 |
| 一般消息 | 重大事项 | 关联交易 | 2020-12-16 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：3.4行业面打败了19%的股票
医疗器械服务行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2021.06.25","price":"1.48","value":"1.56"},{"date":"2021.06.24","price":"-0.40","value":"-1.80"},{"date":"2021.06.23","price":"1.00","value":"-0.14"},{"date":"2021.06.22","price":"0.38","value":"0.85"},{"date":"2021.06.21","price":"0.40","value":"3.08"},{"date":"2021.06.18","price":"0.77","value":"1.60"},{"date":"2021.06.17","price":"1.23","value":"0.63"},{"date":"2021.06.16","price":"-2.57","value":"-1.73"},{"date":"2021.06.15","price":"-0.86","value":"-1.10"},{"date":"2021.06.11","price":"-0.62","value":"-1.54"},{"date":"2021.06.10","price":"1.19","value":"-0.18"},{"date":"2021.06.09","price":"0.01","value":"-0.07"},{"date":"2021.06.08","price":"-0.98","value":"-1.47"},{"date":"2021.06.07","price":"-0.06","value":"0.48"},{"date":"2021.06.04","price":"0.74","value":"0.57"},{"date":"2021.06.03","price":"-0.65","value":"-1.24"},{"date":"2021.06.02","price":"-1.18","value":"-3.13"},{"date":"2021.06.01","price":"0.26","value":"1.10"},{"date":"2021.05.31","price":"0.97","value":"3.97"},{"date":"2021.05.28","price":"-0.30","value":"-1.27"},{"date":"2021.05.27","price":"0.70","value":"1.39"}]
深证成指,医疗器械服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | ST运盛 | 63.16% | 15.63% | 5.5分 |
| 2 | *ST百花 | 35.58% | 10.07% | 5.8分 |
| 3 | 拱东医疗 | 30.03% | -2.76% | 5.7分 |
| 4 | 艾隆科技 | 29.36% | 6.77% | 6.2分 |
| 5 | 东方生物 | 28.96% | 28.23% | 7.4分 |
| 6 | 翔宇医疗 | 25.73% | 24.61% | 6.4分 |
| 8 | 鱼跃医疗 | 18.98% | 1.49% | 6.8分 |
| 10 | 通策医疗 | 16.71% | 8.57% | 7.1分 |
| 12 | 万泰生物 | 15.95% | 0.81% | 6.9分 |
| 14 | 赛诺医疗 | 15.37% | -3.39% | 3.9分 |
| 16 | 爱美客 | 13.06% | 14.19% | 6.5分 |
| 18 | 盈康生命 | 11.87% | 11.36% | 5.5分 |
| 20 | 美迪西 | 11.74% | -3.78% | 5.2分 |
| 22 | 惠泰医疗 | 9.98% | 3.71% | 6.2分 |
| 24 | 奕瑞科技 | 9.45% | 2.05% | 5.8分 |
| 26 | 凯普生物 | 8.62% | 3.96% | 7.0分 |
| 28 | 透景生命 | 7.70% | 17.82% | 6.3分 |
| 30 | 普门科技 | 6.89% | 3.87% | 6.1分 |
| 32 | 热景生物 | 6.71% | 14.59% | 6.5分 |
| 34 | 昭衍新药 | 6.29% | 2.85% | 5.2分 |
| 36 | 博济医药 | 5.23% | 12.35% | 6.1分 |
| 38 | 硕世生物 | 5.06% | 1.16% | 6.1分 |
| 40 | 爱尔眼科 | 4.48% | 4.50% | 6.2分 |
| 42 | 三鑫医疗 | 3.44% | 5.03% | 5.8分 |
| 44 | 新开源 | 3.24% | 6.01% | 5.8分 |
| 46 | 祥生医疗 | 2.79% | 1.38% | 3.9分 |
| 48 | 戴维医疗 | 2.09% | 4.06% | 4.9分 |
| 50 | 万东医疗 | 1.45% | -1.41% | 4.5分 |
| 52 | 开立医疗 | 1.04% | 9.49% | 6.5分 |
| 54 | 济民医疗 | 0.25% | 0.75% | 4.3分 |
| 56 | 海尔生物 | -0.20% | 9.94% | 6.8分 |
| 58 | 迪瑞医疗 | -0.28% | -1.25% | 4.5分 |
| 60 | 之江生物 | -1.30% | 1.41% | 5.3分 |
| 62 | 蓝帆医疗 | -1.63% | 7.19% | 5.9分 |
| 64 | 天臣医疗 | -1.68% | 6.04% | 5.6分 |
| 66 | 三诺生物 | -2.26% | 8.07% | 5.9分 |
| 68 | 博晖创新 | -2.73% | -1.51% | 3.8分 |
| 70 | 凯利泰 | -3.17% | 9.89% | 6.2分 |
| 72 | 新产业 | -3.49% | -2.17% | 4.1分 |
| 74 | 九安医疗 | -3.75% | -0.65% | 4.3分 |
| 76 | 达安基因 | -3.76% | -0.37% | 5.4分 |
| 78 | 奥泰生物 | -3.86% | 0.25% | 4.8分 |
| 80 | 迈瑞医疗 | -4.84% | 2.78% | 5.7分 |
| 82 | 辰欣药业 | -5.11% | 3.07% | 5.0分 |
| 84 | 尚荣医疗 | -5.40% | -0.53% | 4.9分 |
| 86 | 安必平 | -5.84% | 0.46% | 4.1分 |
| 88 | 奥美医疗 | -6.16% | -1.52% | 4.0分 |
| 90 | 华大基因 | -6.20% | -0.18% | 4.6分 |
| 92 | 利德曼 | -6.51% | -0.80% | 4.4分 |
| 94 | 润达医疗 | -6.98% | -3.75% | 4.3分 |
| 96 | 理邦仪器 | -7.25% | -4.08% | 4.7分 |
| 98 | 迪安诊断 | -7.55% | 0.05% | 5.0分 |
| 100 | 美康生物 | -8.81% | 0.64% | 4.4分 |
| 102 | 迈克生物 | -9.58% | 0.89% | 5.2分 |
| 104 | 振德医疗 | -10.01% | -0.09% | 5.0分 |
| 106 | 康泰医学 | -11.05% | -7.45% | 3.8分 |
| 108 | 山东药玻 | -11.83% | 2.95% | 5.0分 |
| 110 | 成都先导 | -12.42% | -0.80% | 4.5分 |
| 112 | 贝瑞基因 | -12.97% | 2.33% | 4.5分 |
| 114 | 澳洋健康 | -14.82% | -2.61% | 4.7分 |
| 116 | 创新医疗 | -18.80% | -4.86% | 4.6分 |
| 118 | 科美诊断 | -19.71% | -7.12% | 4.2分 |
| 120 | 英科医疗 | -26.84% | 6.14% | 6.1分 |
| 122 | 睿昂基因 | -27.86% | -5.55% | 4.0分 |
| 124 | 爱威科技 | - | 0.42% | 4.5分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2021-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 49/257 ， 1/257。
[{"date":"2021-03-31","value":"3.87","vol":"4.68"},{"date":"2020-12-31","value":"16.94","vol":"19.68"},{"date":"2020-09-30","value":"11.52","vol":"16.28"},{"date":"2020-06-30","value":"20.11","vol":"11.22"},{"date":"2020-03-31","value":"6.33","vol":"1.89"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.87 | 16.94 | 11.52 | 20.11 | 6.33 |
| 行业(%) | 4.68 | 19.68 | 16.28 | 11.22 | 1.89 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"92.50","vol":"53.38"},{"date":"2020-12-31","value":"92.17","vol":"53.05"},{"date":"2020-09-30","value":"91.54","vol":"48.99"},{"date":"2020-06-30","value":"90.22","vol":"51.66"},{"date":"2020-03-31","value":"89.83","vol":"46.04"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
92.50 | 92.17 | 91.54 | 90.22 | 89.83 |
| 行业(%) | 53.38 | 53.05 | 48.99 | 51.66 | 46.04 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 15/257 ， 38/257。
[{"date":"2021-03-31","value":"227.52","vol":"156.47"},{"date":"2020-12-31","value":"27.18","vol":"68.23"},{"date":"2020-09-30","value":"17.40","vol":"61.45"},{"date":"2020-06-30","value":"0.72","vol":"49.26"},{"date":"2020-03-31","value":"-20.98","vol":"4.25"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
227.52 | 27.18 | 17.40 | 0.72 | -20.98 |
| 行业(%) | 156.47 | 68.23 | 61.45 | 49.26 | 4.25 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"296.50","vol":"1539.52"},{"date":"2020-12-31","value":"43.93","vol":"223.61"},{"date":"2020-09-30","value":"31.83","vol":"179.47"},{"date":"2020-06-30","value":"14.59","vol":"141.11"},{"date":"2020-03-31","value":"-17.46","vol":"266.95"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
296.50 | 43.93 | 31.83 | 14.59 | -17.46 |
| 行业(%) | 1539.52 | 223.61 | 179.47 | 141.11 | 266.95 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 102/257 ， 64/257。
[{"date":"2021-03-31","value":"0.06","vol":"0.14"},{"date":"2020-12-31","value":"0.26","vol":"0.61"},{"date":"2020-09-30","value":"0.18","vol":"0.44"},{"date":"2020-06-30","value":"0.30","vol":"0.30"},{"date":"2020-03-31","value":"0.11","vol":"0.09"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.06 | 0.26 | 0.18 | 0.30 | 0.11 |
| 行业(次) | 0.14 | 0.61 | 0.44 | 0.30 | 0.09 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"0.72","vol":"22.23"},{"date":"2020-12-31","value":"2.22","vol":"67.90"},{"date":"2020-09-30","value":"1.54","vol":"44.44"},{"date":"2020-06-30","value":"1.05","vol":"25.49"},{"date":"2020-03-31","value":"","vol":"10.93"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.72 | 2.22 | 1.54 | 1.05 | - |
| 行业(次) | 22.23 | 67.90 | 44.44 | 25.49 | 10.93 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2021-03-31","value":"59.70","vol":"1.21"},{"date":"2020-12-31","value":"68.18","vol":"28.38"},{"date":"2020-09-30","value":"64.47","vol":"20.42"},{"date":"2020-06-30","value":"75.86","vol":"23.20"},{"date":"2020-03-31","value":"-10.30","vol":"-9.83"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 59.70 | 68.18 | 64.47 | 75.86 | -10.30 |
| 行业 | 1.21 | 28.38 | 20.42 | 23.20 | -9.83 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"","vol":"0.01"},{"date":"2020-12-31","value":"2.90","vol":"3.09"},{"date":"2020-09-30","value":"","vol":"0.11"},{"date":"2020-06-30","value":"2.88","vol":"2.27"},{"date":"2020-03-31","value":"","vol":"0.08"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.90 | - | 2.88 | - |
| 行业 | 0.01 | 3.09 | 0.11 | 2.27 | 0.08 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 125/257 ， 125/257。
[{"date":"2021-03-31","value":"37.97","vol":"5.48"},{"date":"2020-12-31","value":"49.05","vol":"4.76"},{"date":"2020-09-30","value":"40.02","vol":"5.36"},{"date":"2020-06-30","value":"13.12","vol":"3.82"},{"date":"2020-03-31","value":"","vol":"3.66"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
37.97 | 49.05 | 40.02 | 13.12 | - |
| 行业 | 5.48 | 4.76 | 5.36 | 3.82 | 3.66 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"37.53","vol":"4.61"},{"date":"2020-12-31","value":"48.55","vol":"4.08"},{"date":"2020-09-30","value":"39.57","vol":"4.41"},{"date":"2020-06-30","value":"12.23","vol":"3.07"},{"date":"2020-03-31","value":"","vol":"2.99"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
37.53 | 48.55 | 39.57 | 12.23 | - |
| 行业 | 4.61 | 4.08 | 4.41 | 3.07 | 2.99 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 124/257 ， 124/257。
[{"date":"2021-03-31","value":"3.17","vol":"26.81"},{"date":"2020-12-31","value":"2.19","vol":"28.47"},{"date":"2020-09-30","value":"2.64","vol":"28.55"},{"date":"2020-06-30","value":"7.21","vol":"31.04"},{"date":"2020-03-31","value":"6.29","vol":"27.15"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
3.17 | 2.19 | 2.64 | 7.21 | 6.29 |
| 行业(%) | 26.81 | 28.47 | 28.55 | 31.04 | 27.15 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"0.03","vol":"1.42"},{"date":"2020-12-31","value":"0.02","vol":"1.08"},{"date":"2020-09-30","value":"0.03","vol":"0.82"},{"date":"2020-06-30","value":"0.08","vol":"0.84"},{"date":"2020-03-31","value":"0.07","vol":"0.75"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.03 | 0.02 | 0.03 | 0.08 | 0.07 |
| 行业(%) | 1.42 | 1.08 | 0.82 | 0.84 | 0.75 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 方正证券 | 2021-06-24 | 增持 | 增持 |
| 德邦证券 | 2021-06-20 | 买入 | |
| 中信证券 | 2021-06-09 | 增持 | |
| 申万宏源 | 2021-05-21 | 增持 | 增持 |
| 国盛证券 | 2021-05-16 | 买入 | 买入 |
| 中泰证券 | 2021-05-16 | 买入 | 买入 |
机构预测
机构预测该股2021年每股收益与前一年相同，长期投资价值一般。
[{"date":"2017","yellowRectValue":"0.82","blueLineValue":"","type":""},{"date":"2018","yellowRectValue":"1.23","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"3.06","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"4.40","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"7.12","blueLineValue":"3.36","type":"YC"}]